Ameritas Investment Partners’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$189K Buy
13,522
+930
+7% +$13K 0.01% 1323
2025
Q1
$171K Hold
12,592
0.01% 1360
2024
Q4
$257K Hold
12,592
0.01% 1173
2024
Q3
$367K Buy
12,592
+362
+3% +$10.5K 0.01% 966
2024
Q2
$284K Hold
12,230
0.01% 1044
2024
Q1
$251K Hold
12,230
0.01% 1138
2023
Q4
$262K Buy
12,230
+492
+4% +$10.6K 0.01% 1106
2023
Q3
$242K Buy
11,738
+1,982
+20% +$40.9K 0.01% 1069
2023
Q2
$288K Buy
9,756
+1,047
+12% +$30.9K 0.01% 945
2023
Q1
$201K Hold
8,709
0.01% 1094
2022
Q4
$259K Buy
8,709
+1,240
+17% +$36.8K 0.01% 994
2022
Q3
$229K Hold
7,469
0.01% 996
2022
Q2
$219K Buy
7,469
+335
+5% +$9.82K 0.01% 1019
2022
Q1
$230K Hold
7,134
0.01% 1096
2021
Q4
$318K Hold
7,134
0.01% 948
2021
Q3
$360K Hold
7,134
0.01% 883
2021
Q2
$560K Buy
7,134
+2,019
+39% +$158K 0.02% 762
2021
Q1
$292K Sell
5,115
-153
-3% -$8.73K 0.01% 965
2020
Q4
$441K Sell
5,268
-287
-5% -$24K 0.02% 800
2020
Q3
$199K Hold
5,555
0.01% 1033
2020
Q2
$134K Buy
5,555
+1,362
+32% +$32.9K 0.01% 1239
2020
Q1
$73K Hold
4,193
﹤0.01% 1441
2019
Q4
$73K Buy
4,193
+488
+13% +$8.5K ﹤0.01% 1688
2019
Q3
$57K Hold
3,705
﹤0.01% 1811
2019
Q2
$77K Hold
3,705
﹤0.01% 1662
2019
Q1
$86K Hold
3,705
﹤0.01% 1564
2018
Q4
$77K Hold
3,705
﹤0.01% 1559
2018
Q3
$81K Buy
3,705
+2,343
+172% +$51.2K ﹤0.01% 1695
2018
Q2
$21K Hold
1,362
﹤0.01% 2482
2018
Q1
$27K Buy
+1,362
New +$27K ﹤0.01% 2262